Author

A. Vincent-Salomon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 7 Approach:experimental assay· 4 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:DNA methylation· 2 Assay:imaging· 2 Research Focus:variant calling· 2

Frequent Co-Authors

A. Nicolas· 3 shared D. Meseure· 3 shared M.-H. Stern· 3 shared A. Herbette· 2 shared F. Reyal· 2 shared J.-P. Morretton· 2 shared O. Goundiam· 2 shared O. Mariani· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Nicolas

Mutual co-authors in cluster

Author profile →

7 papers

Recent·Most cited

Centrosome amplification primes for apoptosis and favors the response to chemotherapy in ovarian cancer beyond multipolar divisions

F. Edwards, G. Fantozzi, A. Y. Simon, J.-P. Morretton, A. Herbette, A. E. Tijhuis, R. Wardenaar, S. Foulane, S. Gemble, D. C. J. Spierings, F. Foijer, O. Mariani, A. Vincent-Salomon, S. Roman-Roman, X. Sastre-Garau, , R. Basto

The paper shows centrosome amplification in ovarian cancer cells primes them for apoptosis and improves chemotherapy response, independent of multipolar divisions and chromosome instability.

bioRxiv · Jul 28, 2023 · PreprintCell Biology

EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition

P. Romero, L. Richart, S. Aflaki, M. Burton, A. Michaud, J. Masliah-Planchon, F. Kuhnoswki, C. Meaudre, A. Luscan, A. Hamza, P. Legoix, A. Vincent-Salomon, M. Wassef, D. Holoch, R. Margueron

This study shows that EZH2 mutations in follicular lymphoma alter H3K27 methylation and transcriptional responses to PRC2 inhibition, with clinical implications for patient stratification.

bioRxiv · Jan 2, 2023Cancer Biology

Optical Genome Mapping for detecting Homologous Recombination Deficiency (HRD) in human breast and ovarian cancers

S. Vanhuele, Y. Kirova, A.-S. Hamy-Petit, A. Rapinat, D. Gentien, C. Callens, M.-C. Villy, F. Reyal, A. Vincent-Salomon, A. Eeckhoutte, M. Rodrigues, M.-H. Stern, T. Popova

This study uses Optical Genome Mapping to detect HRD in breast and ovarian cancers by analyzing structural variants, finding isolated translocations as a reliable biomarker.

bioRxiv · Dec 23, 2022 · PreprintCancer Biology

Low centrosome numbers correlate with higher aggressivity in ovarian cancer

J.-P. Morretton, A. Simon, A. Herbette, J. Barbazan, C. Perez-Gonzalez, C. Cosson, B. Mboup, A. Latouche, T. Popova, Y. Kieffer, P. Gestraud, G. Bataillon, V. Becette, D. Meseure, A. Nicolas, , R. Basto

The paper analyzes centrosome numbers in ovarian cancers and finds that low centrosome numbers correlate with poor patient survival and mesenchymal subgroup enrichment.

bioRxiv · Jan 4, 2022 · PreprintCancer Biology

Cancer/Testis genes are predictive of breast tumor subtypes

M. Laisne, S. Benlarama, A. Nicolas, L. Djerroudi, N. Gupta, D. Daher, L. Ferry, O. Kirsh, C. Philippe, Y. Okada, G. Cristofari, D. Meseure, A. Vincent-Salomon, C. Ginestier, P.-A. Defossez

The paper identifies HORMAD1 and CT83 as Cancer/Testis genes predictive of basal-like breast tumors and shows their epigenetic regulation and prognostic significance.

bioRxiv · Oct 27, 2021 · PreprintCancer Biology

Tissue-resident FOLR2+ macrophages associate with tumor-infiltrating CD8+ T cells and with increased survival of breast cancer patients.

R. N. Ramos, Y. Missolo-Koussou, Y. Gerber-Ferder, C. Bromley, M. Bugatti, N. G. Nunez, J. Boari Tosello, W. Richer, J. Denizeau, C. Sedlik, P. Caudana, F. Kotsias, L. L. Niborski, S. Viel, M. Bohec, , J. Helft

The paper identifies FOLR2+ macrophages in breast cancer that correlate with improved patient survival and co-localize with CD8+ T cells across multiple cancers.

bioRxiv · Apr 12, 2021 · PreprintImmunology

A single droplet digital PCR for ESR1 activating mutations detection in plasma

E. Jeannot, L. Darrigues, M. Michel, M.-H. Stern, J.-Y. Pierga, A. Rampanou, S. Melaabi, C. Benoist, I. Bieche, A. Vincent-Salomon, R. El Ayachy, A. Noret, N. Epaillard, L. Cabel, F.-C. Bidard, C. Proudhon

This paper develops a multiplex droplet digital PCR assay for detecting ESR1 activating mutations in plasma, showing high sensitivity and concordance with NGS data.

bioRxiv · Jan 8, 2019Cancer Biology